Prognostic Value of PCNA and Mutant p53 Expression in Laryngeal Squamous Cell Carcinoma

References

• Parkin D. M., Stjensward J., Muir C. S. Estimates of the worldwide frequency of twelve major cancers. Bull. World Health Organ. 1984; 62: 163–182, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Yilmaz T., Hosal A. S., Gedikoglu G., Kaya S. Prognostic significance of histopathological parameters in cancer of the larynx. Eur. Arch. Otorhinolaryngol. 1999; 256: 139–144, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Chang F., Syrjanen S., Syrainen K. Implications of the p53 tumor-suppressor gene in clinical oncology. J. Clin. Oncol. 1995; 13: 1009–1022, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Finlay C. A., Hinds P. W., Tan T. H., Eliyahu D., Oren M., Levine A. L. Activation mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half life. Mol. Cell. Biol. 1988; 8: 531, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Maestro R., Dolcetti R., Gasparotto D., Doglioni C., Pelucchi S., Barzan L., Grandi E., Boiocchi M. High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. Oncogene 1992; 7: 1159–1166, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Youssef E. M., Matsuda T., Takada N., Osugi H., Higashino M., Kinoshita H., Watanabe T., Katsura Y., Wanibuchi H., Fukushima S. Prognostic significance of the MIB-1 proliferation index for patients with squamous cell carcinoma of the esophagus. Cancer 1995; 76: 358–366, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Peruno M., Kennth W., Janos W., Christer B. Expression of proliferating cell nuclear antigen (PCNA) in urinary bladder carcinoma. Evaluation of antigen retrieval methods. APMIS 1992; 100: 988–992
   PubMed Web of Science ®Google Scholar
• Sasano H., Miyazaki S., Gooukon Y., Nishihira T., Sawai T., Nagura H. Expression of p53 in human esophageal carcinoma: an immunohistochemical study with correlation to proliferating cell nuclear antigen expression. Human Pathol. 1992; 23: 1238–1243, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Haapasalo H., Isola J., Sallinen P., Kalimo H., Helin H., Rantala I. Aberrant p53 expression in astrocytic neoplasms of the brain: association with proliferation. Am. J. Pathol. 1993; 142: 1347–1351, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Ahomadegbe J. C., Barrois M., Fogel S., LeBihan M. L., Douc-Rasy S., Duvillard P., Armand J. P., Riou P. High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions. Oncogene 1995; 10: 1217–1227, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Nadal A., Campo E., Pinto J., LeBihan M. L., Douc-Rasy S., Duvillard P., Armand J. P., Riou P. p53 expression in normal dysplastic and neoplastic laryngeal epithelium. Absence of correlation with prognostic factors. J. Pathol. 1995; 175: 181–188, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• UICC International Union Against Cancer: TNM Classification of Malignant Tumors4th ed., P. Hermanek, L. H. Sobin. UICC. 1992, rev 2
   Google Scholar
• Hirvikoski P., Kumpulainen E., Virtaniem J., Johansson R., Haapasalo H., Marin S., Halonen P., Helin H., Raitiola H., Pukander J., Kellokumpu-Lehtinen P., Kosma V. M. p53 expression and cell proliferation as prognostic factors in laryngeal squamous cell carcinoma. J. Clin. Oncol. 1997; 15: 3111–3120, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Thompson A. C., Bradley P. J., Griffin N. R. Tumor-associated tissue eosinophilia and long-term prognosis for carcinoma of the larynx. Am. J. Surg. 1994; 168: 469–471, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Dolcetti R., Doglioni C., Maestro R., Gasparotto D., Barzan L., Pastore A., Romanelli M., Boiocchi M. p53 over-expression is an early event in the development of human squamous-cell carcinoma of the larynx: Genetic and prognostic implications. Int. J. Cancer 1992; 52: 178–18229, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Tomasino R. M., Morello V., Bazan V., Morello V., Tralongo V., Nuara R., Nagar C., Salvato M., Ingria F., Restivo S. p53 expression in stage III–IV squamous-cell carcinoma of the larynx: an immunohistochemical study related to clinicopathological, flow-cytometric DNA analysis and prognosis. Int. J. Oncol. 1994; 5: 495–500
   PubMed Web of Science ®Google Scholar
• Jin Y. T., Kayser S., Kemp B. L., Ordonez N. G., Tucker S. L., Clayman G. L., Goepfert H., Luna M. A., Batsakis J. G., El-Naggar A. K. The prognostic significance of the biomarkers p21WAF1/CIP1, p53, and bcl-2 in laryngeal squamous cell carcinoma. Cancer 1998; 82(11)2159–2165, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Field J. K., Malliri A., Butt S. A., Gosney J. R., Philips D. E., Spandidos D. A., Jones A. S. p53 expression in end stage squamous cell carcinoma of the head and neck prior to chemotherapy treatment: expression correlates with a very poor clinical outcome. Int. J. Oncol. 1993; 3: 431–435
   PubMed Web of Science ®Google Scholar
• Joypaul B. V., Hopwood D., Newman E. L., Qureshi S., Grant A., Ogston S. A., Lane D. P., Cuschieri A. The prognostic significance of the accumulation of p53 tumor-suppressor gene protein in gastric adenocarcinoma. Br. J. Cancer 1994; 69: 943–946, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Golusinski W., Szmeja Z., Olofsson J., Biczysko W., Krygier-Stojalzowska A., Majewski P. Retrospective analysis of selected tumor markers (p53, PCNA, Ki67; DNA ploidy) and ultrastructure in patients with larynx carcinomas. HNO 1998; 46: 233–240, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Golusinski W., Olofsson J., Szmeja Z., Szyfter K., Szyfter W., Biczysko W., Hemminki K. Alteration of p53 gene structure and function in laryngeal squamous cell cancer. Eur. Arch. Otorhinolaryngol. 1997; 254: 133–137
   PubMedGoogle Scholar
• Chauvel P., Courdi A., Gioanni J., Vallicioni J., Santini J., Dernard F. The labelling index: a prognostic factor in head and neck carcinoma. Radiother. Oncol. 1989; 14: 231–237, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Welkoborsky H. J., Hinni M., Dienes H. P., Mann W. J. Predicting recurrence and survival in patients with laryngeal cancer by means of DNA cytometry, tumor front grading, and proliferation markers. Ann. Otol. Rhinol. Laryngol. 1995; 104: 503–510, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Urpegui Garcia A. M., Morandeira Garcia M. J., Soria Navarro J., Rivas Rodriguez P., Valencia Julve J., Fernandez Larripa S., Valles Varela H. Immunohistochemical markers of cell proliferation in laryngeal carcinoma. Acta Otorrinolaringol. Esp. 2000; 51: 279–287, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Dobros W., Rys J., Niezabitowski A., Olszewski E. The prognostic value of proliferating cell nuclear antigen (PCNA) in the advanced cancer of larynx. Auris, Nasus, Larynx 1998; 25: 295–301, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar